Financhill
Back

AN2 Therapeutics Stock Predictions

AN2 Therapeutics Stock Forecast

  • Is AN2 Therapeutics Stock Undervalued?
    The current AN2 Therapeutics [ANTX] share price is $1.38. The Score for ANTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ANTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will AN2 Therapeutics Stock Go Up Next Year?

Data Unavailable

AN2 Therapeutics Stock Rating

Data Unavailable

AN2 Therapeutics Stock Price History

Is ANTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
an2therapeutics.com

52-Week Data

52-Week High:
22.22
52-Week Low:
0.87

Prediction Charts

Market Cap:
41.2M
Price in USD:
1.38
Volume:
88.7K
Beta:
0.11

Technical Analysis

SMA50:
1.24
SMA100:
1.19
SMA200:
1.86
52-Wk Change:
-93.38%

Stock Predictions

  • Is AN2 Therapeutics stock public?
    Yes, AN2 Therapeutics is a publicly traded company.
  • What is the AN2 Therapeutics stock quote today?
    The AN2 Therapeutics stock price is 1.38 USD today.
  • How to buy AN2 Therapeutics stock online?
    You can buy AN2 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 1.41 1.44 1.48 1.40
Dec-9 1.45 1.42 1.50 1.40
Dec-10 1.43 1.51 1.57 1.42
Dec-11 1.57 1.55 1.59 1.48
Dec-12 1.53 1.48 1.53 1.47
Dec-13 1.48 1.43 1.48 1.43
Dec-16 1.46 1.35 1.46 1.33
Dec-17 1.34 1.34 1.37 1.32
Dec-18 1.34 1.32 1.37 1.31
Dec-19 1.31 1.27 1.32 1.23
Dec-20 1.25 1.26 1.28 1.24
Dec-23 1.27 1.40 1.43 1.26
Dec-24 1.42 1.36 1.42 1.34
Dec-26 1.34 1.38 1.41 1.34

AN2 Therapeutics Earnings

Data Unavailable

AN2 Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.

* AN2 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.